1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Ofatumumab
Trade Name:
Kesimpta
Manufacturer/Distributor:
Novartis Pharmaceuticals
Classification:
Immunomudulator
ATC Class:
L01XC10 - ofatumumab
Status:
active
Notice of Compliance (yyyy/mm/dd):
2021/01/22
Date Marketed in Canada (yyyy/mm/dd):
2021/04/08
Presentation:
20 mg/0.4 mL injection. DIN: 02511355 (pre-filled pen)
20 mg/0.4 mL injection. DIN: 02511363 (pre-filled syringe)
Comments:
For treatment of adults with relapsing remitting multiple sclerosis.
Back to:
Drug Product Listings 
